Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03192059
Title Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer (PRIMMO)
Acronym PRIMMO
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors University Hospital, Ghent
Indications
Therapies
Age Groups: senior | adult
Covered Countries BEL

Facility Status City State Zip Country Details
University Hospital Antwerp Antwerp Belgium Details
Institut Jules Bordet Brussels 1000 Belgium Details
University Hospital Gent Gent 9000 Belgium Details
CMSE Namur Namur Belgium Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field